Abridge, a Pittsburgh, PA-based AI-powered healthcare company, has secured $300 million in Series E funding at a $5.3 billion valuation.
Investors
The round was led by Andreessen Horowitz, with participation from Khosla Ventures.
Andreessen Horowitz is a venture capital firm focused on investing in and supporting technology-driven companies. It invests across various stages, from seed funding to later-stage growth rounds, and manages a substantial $43 billion in assets through multiple funds.
Abridge Use of Funds
The company will use the funds to support its expansion into AI-powered medical coding, in addition to scaling its core medical scribe technology.
About Abridge
Abridge is uses generative AI to automate clinical documentation. Its AI platform automatically captures and summarizes patient-clinician conversations in real-time, converting them into structured, clinically accurate, and billable notes. Headquartered in Pittsburgh, Pennsylvania, the company serves over 150 enterprise health systems across 55 specialties and 28 languages. Abridge's mission is to power deeper understanding in healthcare through purpose-built AI.
Funding Details
Company: Abridge AI, Inc.
Raised: $300.0M
Round: Series E
Funding Date: June 2025
Lead Investor: Andreessen Horowitz (a16z)
Additional Investors: Khosla Ventures
Company Website: https://www.abridge.com/
Software Category: Healthcare AI / Revenue Cycle Management / Clinical Documentation
Source: https://techcrunch.com/2025/06/24/in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b/